| human | Q5 |
| P496 | ORCID iD | 0000-0003-3145-2440 |
| P1053 | ResearcherID | J-2404-2016 |
| T-7070-2018 | ||
| P1153 | Scopus author ID | 17344307800 |
| P69 | educated at | National University of Colombia | Q1150419 |
| Our Lady of the Rosary University | Q3997334 | ||
| P108 | employer | Our Lady of the Rosary University | Q3997334 |
| P735 | given name | Adriana | Q374807 |
| Adriana | Q374807 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q56452203 | AB0403 Cigarette smoking and coffee consumption independently influence the risk of developing cardiovascular disease in systemic lupus erythematosus |
| Q56452472 | Anti-CCP antibodies are associated with early age at onset in patients with rheumatoid arthritis |
| Q56451937 | Anti-CCP antibodies as a marker of rhupus |
| Q52937133 | Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis. |
| Q37946085 | Are autoimmune diseases predictable? |
| Q37955572 | Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity |
| Q38022371 | Autoimmune diseases in the intensive care unit. An update |
| Q38266370 | Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus |
| Q36421188 | Autoimmune thyroid disease in rheumatoid arthritis: a global perspective |
| Q41241647 | Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine |
| Q51771654 | Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. |
| Q55278608 | Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression. |
| Q47412459 | Can Appropriate Systemic Treatment Help Protect the Cornea in Patients With Rheumatoid Arthritis? A Multidisciplinary Approach to Autoimmune Ocular Involvement |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
| Q56452046 | Cardiovascular disease in the antiphospholipid syndrome |
| Q51773790 | Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q92506920 | Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort |
| Q96582151 | Colchicine as a possible therapeutic option in COVID-19 infection |
| Q41823763 | Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus |
| Q94539926 | Convalescent plasma in Covid-19: Possible mechanisms of action |
| Q92739400 | Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort |
| Q58491706 | Correlación y concordancia de la autoclinimetría en artritis reumatoide: revisión sistemática de la literatura y metanálisis |
| Q91632184 | Corrigendum to 'Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis'. [AUTREV 18-2 (2019) 184-191] |
| Q39746865 | Definition of mutations in polyautoimmunity |
| Q56452747 | Delayed lupus nephritis |
| Q38273840 | Does non-erosive rheumatoid arthritis exist? A cross-sectional analysis and a systematic literature review |
| Q89803222 | Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis |
| Q58491735 | Enfermedad de superficie ocular por síndrome de Stevens-Johnson tratada con ciclosporina oral |
| Q35207467 | Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction |
| Q37917207 | Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases |
| Q34917266 | Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). |
| Q56452115 | FRI0409 Smoking and SjÖGren's Syndrome Are Predictors of Autoimmune Thyroid Disease in Systemic Lupus Erythematosus: Table 1 |
| Q51610326 | Factors influencing polyautoimmunity in systemic lupus erythematosus. |
| Q36366934 | Familial Aggregation and Segregation Analysis in Families Presenting Autoimmunity, Polyautoimmunity, and Multiple Autoimmune Syndrome |
| Q37360727 | Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. |
| Q35671305 | GDF15(MIC1) H6D Polymorphism Does Not Influence Cardiovascular Disease in a Latin American Population with Rheumatoid Arthritis |
| Q38065383 | Gender differences in Latin-American patients with rheumatoid arthritis |
| Q34224612 | HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies |
| Q37337315 | HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis |
| Q38349069 | HLA class II polymorphism in Latin American patients with multiple sclerosis. |
| Q37766369 | HLA-Class II in Latin American patients with type 1 diabetes |
| Q34622288 | How do autoimmune diseases cluster in families? A systematic review and meta-analysis |
| Q45136679 | Human leukocyte antigen class II and type 1 diabetes in Latin America: a combined meta-analysis of association and family-based studies |
| Q58491698 | Impact of educational level on rheumatoid arthritis: A systematic review |
| Q35791637 | Introducing polyautoimmunity: secondary autoimmune diseases no longer exist |
| Q56452497 | Les anticorps anti-CCP sont associés avec un âge de début précoce de la polyarthrite rhumatoïde |
| Q37834473 | Lupus nephritis in Colombians: contrasts and comparisons with other populations |
| Q34754498 | Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. |
| Q34019296 | Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases |
| Q35670523 | Novel and rare functional genomic variants in multiple autoimmune syndrome and Sjögren's syndrome |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q26860327 | Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis |
| Q36375678 | Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis |
| Q58491746 | Paget Disease of Bone in Colombia and Latin America |
| Q38391298 | Personalized medicine. Closing the gap between knowledge and clinical practice |
| Q56452712 | Polyautoimmunity and familial autoimmunity in systemic sclerosis |
| Q38901464 | Polyautoimmunity in Sjögren Syndrome |
| Q38070211 | Prevalence and clinical features of multiple sclerosis in Latin America |
| Q35571575 | Prevalence of celiac disease in latin america: a systematic review and meta-regression |
| Q90672393 | Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis |
| Q38920709 | Pulmonary involvement in systemic sclerosis |
| Q33429418 | Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy |
| Q91456172 | Reply to the editor |
| Q41137156 | Rheumatoid arthritis in minorities |
| Q42651242 | Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. |
| Q37059860 | Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature |
| Q56452090 | SAT0055 Exploration of Risk Factors for Rheumatoid Arthritis Using Advance Recursive Partitioning Approach |
| Q56452759 | STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians |
| Q58491693 | Sacroiliitis séptica por Escherichia coli en el puerperio tardío |
| Q34066226 | Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis. |
| Q35936621 | Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis |
| Q56452729 | Should Rituximab be Considered as the First-Choice Treatment for Severe Autoimmune Rheumatic Diseases? |
| Q56452343 | Sjögren’s syndrome at the crossroad of polyautoimmunity |
| Q35778847 | Spondyloarthropathies in autoimmune diseases and vice versa |
| Q98191401 | Subcutaneous abatacept in rheumatoid arthritis: A real-life experience |
| Q45091373 | Systemic sclerosis: a world wide global analysis. |
| Q54536891 | TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. |
| Q80613036 | TNF microsatellites polymorphism is associated with rheumatoid arthritis. Confirming evidence in northwestern Colombians |
| Q26747427 | The Autoimmune Ecology |
| Q56452765 | The Multiple Autoimmune Syndromes |
| Q56452307 | The Multiple Autoimmune Syndromes. A Clue for the Autoimmune Tautology |
| Q42150403 | The autoimmune tautology: from polyautoimmunity and familial autoimmunity to the autoimmune genes |
| Q34400681 | The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians |
| Q33467606 | The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis. |
| Q56452789 | The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity |
| Q41928172 | Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. |
| Q36916682 | Tuberculosis in patients treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile? |
| Q58491689 | Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist? |
| Q52659257 | Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus. |
| Q36302285 | Usefulness of patients-reported outcomes in rheumatoid arthritis focus group |
| Q37784279 | ZC3H12A (MCPIP1): molecular characteristics and clinical implications |
| Q95272715 | [Colchicine: a potential therapeutic tool against COVID-19. Experience of 5 patients] |
Search more.